PLRX

PLIANT THERAPEUTICS, INC.

SEC CIK 1746473
$1.16 +0.0% · 90 days
90-day buys
$0
0 open-market
90-day sells
$0
0 open-market
Net insider flow
+$0
Net buying
Filings shown
18
Most recent
Advertisement

At a glance

Insiders at PLRX have made no open-market trades in the last 90 days — the activity below is grants, option exercises, and other routine filings.

Largest recent trade: Hull Hans sold $401.2K of PLRX, trimming their stake 9%.

Most active filer: Hull Hans, with 10 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for PLRX, newest first
View on SEC EDGAR ↗
PLRX
Sell Cummings Keith Lamont · Chief Financial Officer · Open-market sale · filed Jan 22, 2026 ΔOwn −7.5%

Cummings Keith Lamont sold $30.7K of PLRX, trimming their stake 7%.

−$30.7K
24,002 sh @ $1
PLRX
Sell Cheung Lily · Chief Human Resource Officer · Open-market sale · filed Jan 22, 2026 ΔOwn −14%

Cheung Lily sold $9.6K of PLRX, trimming their stake 14%.

−$9.6K
7,534 sh @ $1
PLRX
Sell Coulie Bernard · Director, President and CEO · Open-market sale · filed Jan 22, 2026 ΔOwn −15%

Coulie Bernard sold $114.4K of PLRX, trimming their stake 15%.

−$114.4K
89,375 sh @ $1
PLRX
Sell Kuo Minnie · Chief Operating Officer · Open-market sale · filed Jan 22, 2026 ΔOwn −15%

Kuo Minnie sold $8.9K of PLRX, trimming their stake 15%.

−$8.9K
6,917 sh @ $1
Advertisement
PLRX
Sell Hull Hans · Chief Business Officer · Open-market sale · filed Jan 22, 2025 ΔOwn −7.0%

Hull Hans sold $178.5K of PLRX, trimming their stake 7%.

−$178.5K
15,936 sh @ $11
PLRX
Sell Cheung Lily · Chief Human Resource Officer · Open-market sale · filed Jan 22, 2025 ΔOwn −13%

Cheung Lily sold $41.9K of PLRX, trimming their stake 13%.

−$41.9K
3,740 sh @ $11
PLRX
Sell Hull Hans · Chief Business Officer · Open-market sale · filed Jul 12, 2024 ΔOwn −4.2%

Hull Hans sold $114.4K of PLRX, trimming their stake 4%.

−$114.4K
9,900 sh @ $12
PLRX
Sell Hull Hans · Chief Business Officer · Open-market sale · filed Jan 19, 2024 ΔOwn −5.0%

Hull Hans sold $168.6K of PLRX, trimming their stake 5%.

−$168.6K
9,786 sh @ $17
PLRX
Sell Hull Hans · Chief Business Officer · Open-market sale · filed Aug 7, 2023 ΔOwn −9.3%

Hull Hans sold $401.2K of PLRX, trimming their stake 9%.

−$401.2K
20,050 sh @ $20
PLRX
Sell Hull Hans · Chief Business Officer · Open-market sale · filed Aug 7, 2023 ΔOwn −6.0%

Hull Hans sold $261.4K of PLRX, trimming their stake 6%.

−$261.4K
13,069 sh @ $20
PLRX
Sell Hull Hans · Chief Business Officer · Open-market sale · filed Aug 7, 2023 ΔOwn +0.9%

Hull Hans sold $36K of PLRX.

+$36K
1,800 sh @ $20
PLRX
Sell Hull Hans · Chief Business Officer · Open-market sale · filed Jul 19, 2023 ΔOwn −7.6%

Hull Hans sold $323K of PLRX, trimming their stake 8%.

−$323K
17,937 sh @ $18
PLRX
Sell Hull Hans · Chief Business Officer · Open-market sale · filed Apr 3, 2023 ΔOwn −4.3%

Hull Hans sold $239.6K of PLRX, trimming their stake 4%.

−$239.6K
9,036 sh @ $27
PLRX
Sell Hull Hans · Chief Business Officer · Open-market sale · filed Dec 21, 2022 ΔOwn −6.0%

Hull Hans sold $167.1K of PLRX, trimming their stake 6%.

−$167.1K
8,748 sh @ $19
Advertisement

About PLRX insider activity

This page tracks every recent Form 4 filed for PLIANT THERAPEUTICS, INC. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is PLRX insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for PLIANT THERAPEUTICS, INC. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.